600 healthy volunteers test malaria Drug's Long-Term eye safety
NCT ID NCT03320174
First seen Apr 23, 2026 · Last updated Apr 25, 2026 · Updated 1 time
Summary
This study looked at the long-term safety of a malaria drug called tafenoquine in 600 healthy adults. Participants took either the drug or a placebo daily for three days, then weekly for 51 weeks. The main goal was to check for serious eye problems, and researchers also monitored other side effects. The study was completed and provides important safety information for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
-
Retina Consultants of Southern Colorado
Colorado Springs, Colorado, 80909, United States
-
Valley Retina Institute
McAllen, Texas, 78503, United States
Conditions
Explore the condition pages connected to this study.